← Open Payments lookup

ROBERT LOEHR: Open Payments

NPI 1851351464 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,464 in 78 payments from 10 companies in 2025. Trend: 2023 $237 · 2024 $910 · 2025 $1,464

Food & beverage: $1,458Education: $7
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.10$348
ABBVIE INC.19$289
Teva Pharmaceuticals USA, Inc.16$245
Vanda Pharmaceuticals Inc.16$242
Alkermes, Inc.10$200
Otsuka America Pharmaceutical, Inc.2$50
Neurocrine BioSciences, Inc.2$43
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Janssen Pharmaceuticals, Inc1$14
Corium, LLC1$13

Products named: COBENFY, VRAYLAR, AUSTEDO XR, HETLIOZ, ARISTADA, REXULTI, LYBALVI, FANAPT.

Industry payments across KS — which companies pay providers there.